·¬ΗΡΙηΗψapp

Oncology/Hematology

Hemophilia

More in Hemophilia

What to Know About the U.K.'s Tainted Blood Scandal

Tens of thousands contracted HIV or hepatitis from transfusions during the 1970s and 1980s

May 20, 2024
 A photo of infected blood victim Brendan West.
FDA OKs Second Gene Therapy for Hemophilia B

One dose of fidanacogene elaparvovec proved noninferior to standard prophylactic factor IX

Apr 26, 2024
Illustration of red blood cells.
Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations

News, features, and commentary about cancer-related issues

Mar 29, 2024
Onco Break over a computer rendering of a cancer cell.
Gene Therapy for Hemophilia Becomes a Reality

Uptake of new options for hemophilia A and B has been a bit slow

Dec 29, 2023
A computer rendering of a ruptured artery leaking blood.
Novel Monoclonal Antibody Reduces Bleeds in Hemophilia A and B

Marstacimab reduced the annualized bleeding rate versus on-demand, prophylactic treatments

Dec 12, 2023
ASH over a photo of San Diego Convention Center.
Emicizumab Safe, Effective, in Infants With Hemophilia A

More than half of children in study had no treated bleeds at follow-up of more than 100 weeks

Dec 10, 2023
ASH over a photo of San Diego Convention Center.
Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDS

News, features, and commentary about cancer-related issues

Oct 27, 2023
Onco Break over a computer rendering of a cancer cell.
Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia A

"Strategy will probably be practice-changing," says expert

Oct 18, 2023
A photo of a box of Hemlibra for injection over a computer rendering of red blood cells.
Concizumab Prophylaxis Reduced Bleeding Rates in Hemophilia

Phase III trial shows 86% reduction in treated bleeds in hemophilia A and B with inhibitors

Aug 30, 2023
A computer rendering of red blood cells and platelets healing a wound.
FDA Gives Nod to Gene Therapy for Hemophilia A

First gene therapy approved for severe hemophilia A

Jun 29, 2023
FDA APPROVED valoctocogene roxaparvovec-rvox (Roctavian) over a computer rendering of a leaking blood vessel.
'Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advances

News, features, and commentary about cancer-related issues

Mar 03, 2023
Onco Break over a computer rendering of a cancer cell.
FDA Approves Weekly Factor Therapy for Hemophilia A

Factor VIII replacement therapy provides protection from bleeds with once-weekly dosing

Feb 23, 2023
FDA APPROVED Altuviiio over a computer rendering of a clot forming on a damaged blood vessel.
Gene Tx Shows Sustained Bleeding Control in Severe Hemophilia A at 2 Years

Model predicts valoctocogene roxaparvovec could maintain mild hemophilia levels for 5 years

Feb 23, 2023
A computer rendering of a clot forming in a broken blood vessel.
New Class of Factor VIII Replacement Therapy Prevents Bleeds in Severe Hemophilia A

Weekly dosing with efanesoctocog alfa reduced annualized bleeding rate by 77%

Jan 25, 2023
A computer rendering of red blood cells and platelets in a blood vessel.
More in Hemophilia